Y10S 435/832
Bacillus
Y10S435/832 (Bacillus) appears on 828 US grants and 66 published applications in this corpus.
Search patents in Y10S- Granted patents
- 828
- Published applications
- 66
- Assignees
- 369
- Inventors
- 1,543
- Latest grant
- 7 Oct 2014
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 40 | 0 |
| 1977 | 45 | 0 |
| 1978 | 27 | 0 |
| 1979 | 9 | 0 |
| 1980 | 16 | 0 |
| 1981 | 19 | 0 |
| 1982 | 15 | 0 |
| 1983 | 13 | 0 |
| 1984 | 20 | 0 |
| 1985 | 18 | 0 |
| 1986 | 28 | 0 |
| 1987 | 19 | 0 |
| 1988 | 24 | 0 |
| 1989 | 26 | 0 |
| 1990 | 37 | 0 |
| 1991 | 38 | 0 |
| 1992 | 34 | 0 |
| 1993 | 42 | 0 |
| 1994 | 50 | 0 |
| 1995 | 33 | 0 |
| 1996 | 42 | 0 |
| 1997 | 26 | 0 |
| 1998 | 43 | 0 |
| 1999 | 25 | 0 |
| 2000 | 28 | 0 |
| 2001 | 26 | 2 |
| 2002 | 14 | 11 |
| 2003 | 13 | 6 |
| 2004 | 6 | 8 |
| 2005 | 7 | 10 |
| 2006 | 13 | 8 |
| 2007 | 4 | 4 |
| 2008 | 2 | 5 |
| 2009 | 5 | 3 |
| 2010 | 5 | 2 |
| 2011 | 7 | 4 |
| 2012 | 4 | 1 |
| 2013 | 1 | 2 |
| 2014 | 4 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Thuricin CD, an antimicrobial for specifically targeting Clostridium difficile7 Oct 2014US 8,852,917 B2Teagasc, The Agriculture and Food Development Authority
- Thrombolytic enzyme and a process for its preparation16 Sep 2014US 8,835,145 B2India and Malladi Drugs Pharmaceuticals Ltd.
- Methods for inhibiting microbial infections associated with sanitary products and for enhancing sanitary product degradation2 Sep 2014US 8,821,854 B2Ganeden Biotech, Inc.
- Identification of toxin-binding protein involved in resistance to Cry1 toxins, and related screening methods12 Aug 2014US 8,802,389 B2University of Georgia Research Foundation, Inc.
- Methods and compositions for the dietary management of autoimmune disorders2 Apr 2013US 8,409,591 B2Ganeden Biotech, Inc.
- Methods And Compositions For The Dietary Management Of Autoimmune Disorders22 Aug 2013US 2013/0216577 A1
- Inhibition of Pathogens by Probiotic Bacteria27 Jun 2013US 2013/0164398 A1Ganeden Biotech, Inc.
- Identification of toxin-binding protein involved in resistance to cry1 toxins, and related screening methods9 Feb 2012US 2012/0034610 A1University of Georgia Research Foundation, Inc.
- Bacillus amyloliquefaciens Strain10 Nov 2011US 2011/0274673 A1Novozymes Biologicals, Inc.
- Inhibition of Pathogens by Probiotic Bacteria4 Aug 2011US 2011/0189145 A1Ganeden Biotech, Inc.
Most cited
By later US patents
- Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases542US 5,633,435 AMonsanto Company · 1997
- Bioconversion of waste biomass to useful products285US 5,821,111 ABioengineering Resources, Inc. · 1998
- Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases257US 5,627,061 AMonsanto Company · 1997
- Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases207US 6,248,876 B1Monsanto Company · 2001
- Biologically active drug polymer derivatives and method for preparing same160US 5,286,637 ADebiopharm S.A. · 1994